118 related articles for article (PubMed ID: 34092607)
21. A Preoperative Measurement of Serum MicroRNA-125b May Predict the Presence of Microvascular Invasion in Hepatocellular Carcinomas Patients.
Liu M; Wang L; Zhu H; Rong W; Wu F; Liang S; Xu N; Wu J
Transl Oncol; 2016 Jun; 9(3):167-72. PubMed ID: 27267832
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients.
Wang MD; Xiang H; Hong TY; Mierxiati A; Yan FH; Zhang L; Wang C
BMC Cancer; 2023 Jun; 23(1):593. PubMed ID: 37370037
[TBL] [Abstract][Full Text] [Related]
23. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.
Du M; Chen L; Zhao J; Tian F; Zeng H; Tan Y; Sun H; Zhou J; Ji Y
BMC Cancer; 2014 Jan; 14():38. PubMed ID: 24460749
[TBL] [Abstract][Full Text] [Related]
24. A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience.
Schlichtemeier SM; Pang TC; Williams NE; Gill AJ; Smith RC; Samra JS; Lam VW; Hollands M; Richardson AJ; Pleass HC; Nozawa S; Albania M; Hugh TJ
Eur J Surg Oncol; 2016 Oct; 42(10):1576-83. PubMed ID: 27378158
[TBL] [Abstract][Full Text] [Related]
25. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma.
Xu X; Zhang HL; Liu QP; Sun SW; Zhang J; Zhu FP; Yang G; Yan X; Zhang YD; Liu XS
J Hepatol; 2019 Jun; 70(6):1133-1144. PubMed ID: 30876945
[TBL] [Abstract][Full Text] [Related]
26. Platelet-to-Lymphocyte Ratio and Large Tumor Size Predict Microvascular Invasion after Resection for Hepatocellular Carcinoma.
Rungsakulkij N; Mingphruedhi S; Suragul W; Tangtawee P; Muangkaew P; Aeesoa S
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3435-3441. PubMed ID: 30583666
[TBL] [Abstract][Full Text] [Related]
27. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.
Han J; Li ZL; Xing H; Wu H; Zhu P; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Wu MC; Shen F; Yang T
HPB (Oxford); 2019 Aug; 21(8):962-971. PubMed ID: 30718183
[TBL] [Abstract][Full Text] [Related]
28. SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort.
Schlichtemeier SM; Nahm CB; Xue A; Gill AJ; Smith RC; Hugh TJ
J Surg Res; 2019 Jun; 238():127-136. PubMed ID: 30771682
[TBL] [Abstract][Full Text] [Related]
29. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
30. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.
Imura S; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Saito Y; Iwahashi S; Ikemoto T; Morine Y; Shimada M
Int J Clin Oncol; 2018 Feb; 23(1):98-103. PubMed ID: 28875240
[TBL] [Abstract][Full Text] [Related]
31. New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation.
Iguchi T; Shirabe K; Aishima S; Wang H; Fujita N; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Oda Y; Maehara Y
Transplantation; 2015 Jun; 99(6):1236-42. PubMed ID: 25427164
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
[TBL] [Abstract][Full Text] [Related]
33. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
34. [The prognostic analysis of hepatocellular carcinoma based on the tumor neo-vessels, macrophages and α-SMA in tumor microenvironment].
Fang M; Yuan JP; Liu LL; Cheng GP; Ying HJ; Chen YM; Chen M
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):518-523. PubMed ID: 28728298
[No Abstract] [Full Text] [Related]
35. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
[TBL] [Abstract][Full Text] [Related]
36. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA.
El-Fattah MA
Indian J Gastroenterol; 2017 Mar; 36(2):117-125. PubMed ID: 28194604
[TBL] [Abstract][Full Text] [Related]
38. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
39. Association of Preoperative Hypercoagulability with Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Liver Resection: A Multicenter Study.
Zhang XP; Zhou TF; Wang ZH; Zhang F; Zhong CQ; Hu YR; Wang K; Chai ZT; Chen ZH; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2019 Nov; 26(12):4117-4125. PubMed ID: 31321582
[TBL] [Abstract][Full Text] [Related]
40. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
